126 related articles for article (PubMed ID: 24955552)
1. Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients.
Mokhber N; Abdollahian E; Soltanifar A; Samadi R; Saghebi A; Haghighi MB; Azarpazhooh A
Pharmacopsychiatry; 2014 Jul; 47(4-5):131-40. PubMed ID: 24955552
[TBL] [Abstract][Full Text] [Related]
2. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A
Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220
[TBL] [Abstract][Full Text] [Related]
3. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.
Lyketsos CG; DelCampo L; Steinberg M; Miles Q; Steele CD; Munro C; Baker AS; Sheppard JM; Frangakis C; Brandt J; Rabins PV
Arch Gen Psychiatry; 2003 Jul; 60(7):737-46. PubMed ID: 12860778
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder.
Shelton RC; Haman KL; Rapaport MH; Kiev A; Smith WT; Hirschfeld RM; Lydiard RB; Zajecka JM; Dunner DL
J Clin Psychiatry; 2006 Nov; 67(11):1674-81. PubMed ID: 17196045
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
6. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
Hoehn-Saric R; Ninan P; Black DW; Stahl S; Greist JH; Lydiard B; McElroy S; Zajecka J; Chapman D; Clary C; Harrison W
Arch Gen Psychiatry; 2000 Jan; 57(1):76-82. PubMed ID: 10632236
[TBL] [Abstract][Full Text] [Related]
7. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
Freeman EW; Rickels K; Sondheimer SJ; Polansky M
Arch Gen Psychiatry; 1999 Oct; 56(10):932-9. PubMed ID: 10530636
[TBL] [Abstract][Full Text] [Related]
8. Specificity profile of venlafaxine and sertraline in major depression: metaregression of double-blind, randomized clinical trials.
Gibiino S; Marsano A; Serretti A
Int J Neuropsychopharmacol; 2014 Jan; 17(1):1-8. PubMed ID: 23953038
[TBL] [Abstract][Full Text] [Related]
9. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
[TBL] [Abstract][Full Text] [Related]
11. Normalization of EEG in depression after antidepressant treatment with sertraline? A preliminary report.
van der Vinne N; Vollebregt MA; Boutros NN; Fallahpour K; van Putten MJAM; Arns M
J Affect Disord; 2019 Dec; 259():67-72. PubMed ID: 31437703
[TBL] [Abstract][Full Text] [Related]
12. ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.
Schatzberg AF; DeBattista C; Lazzeroni LC; Etkin A; Murphy GM; Williams LM
Am J Psychiatry; 2015 Aug; 172(8):751-9. PubMed ID: 25815420
[TBL] [Abstract][Full Text] [Related]
13. A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial.
Etkin A; Patenaude B; Song YJ; Usherwood T; Rekshan W; Schatzberg AF; Rush AJ; Williams LM
Neuropsychopharmacology; 2015 May; 40(6):1332-42. PubMed ID: 25547711
[TBL] [Abstract][Full Text] [Related]
14. Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease.
Munro CA; Longmire CF; Drye LT; Martin BK; Frangakis CE; Meinert CL; Mintzer JE; Porsteinsson AP; Rabins PV; Rosenberg PB; Schneider LS; Weintraub D; Lyketsos CG;
Am J Geriatr Psychiatry; 2012 Dec; 20(12):1036-44. PubMed ID: 23032478
[TBL] [Abstract][Full Text] [Related]
15. Venlafaxine and sertraline does not affect the expression of genes regulating stress response in female MDD patients.
Banach E; Szczepankiewicz A; Leszczyńska-Rodziewicz A; Pawlak J; Dmitrzak-Węglarz M; Zaremba D; Twarowska-Hauser J
Psychiatr Pol; 2017 Dec; 51(6):1029-1038. PubMed ID: 29432501
[TBL] [Abstract][Full Text] [Related]
16. Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.
Weintraub D; Rosenberg PB; Drye LT; Martin BK; Frangakis C; Mintzer JE; Porsteinsson AP; Schneider LS; Rabins PV; Munro CA; Meinert CL; Lyketsos CG;
Am J Geriatr Psychiatry; 2010 Apr; 18(4):332-40. PubMed ID: 20220589
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine.
Vanderkooy JD; Kennedy SH; Bagby RM
Can J Psychiatry; 2002 Mar; 47(2):174-80. PubMed ID: 11926080
[TBL] [Abstract][Full Text] [Related]
18. Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report.
van Dinteren R; Arns M; Kenemans L; Jongsma ML; Kessels RP; Fitzgerald P; Fallahpour K; Debattista C; Gordon E; Williams LM
Eur Neuropsychopharmacol; 2015 Nov; 25(11):1981-90. PubMed ID: 26282359
[TBL] [Abstract][Full Text] [Related]
19. Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.
Barber JP; Barrett MS; Gallop R; Rynn MA; Rickels K
J Clin Psychiatry; 2012 Jan; 73(1):66-73. PubMed ID: 22152401
[TBL] [Abstract][Full Text] [Related]
20. Caregiver assessment of patients' depression in Alzheimer disease: longitudinal analysis in a drug treatment study.
Rosenberg PB; Mielke MM; Lyketsos CG
Am J Geriatr Psychiatry; 2005 Sep; 13(9):822-6. PubMed ID: 16166413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
